Medtronic pushes Hugo toward broader U.S. adoption as robotic surgery competition intensifies
Medtronic’s Hugo filings could widen U.S. robotic surgery competition. Find out how the FDA review may challenge Intuitive Surgical.
Medtronic’s Hugo filings could widen U.S. robotic surgery competition. Find out how the FDA review may challenge Intuitive Surgical.
CereVasc’s $85m raise backs eShunt, a minimally invasive hydrocephalus device. The STRIDE trial now carries the real test.
HeartBeam’s ECG evidence could push chest pain assessment closer to patients. The next test is FDA clarity and clinical trust.
GE HealthCare’s MIM Contour ProtégéAI+ 2.0 clearance could speed radiation therapy planning. Find out what changes next.
SOPHiA GENETICS and Memorial Sloan Kettering aim to turn cancer data into precision oncology infrastructure. Can the hub deliver?
Zepto’s FungiFlex brings liquid biopsy to invasive mold infections. The FDA designation tests whether faster fungal diagnosis can change care.
Philips’ Elevate Plus puts AI inside ultrasound workflows. The real test is whether hospitals see faster scans and fewer repeat exams.
Find out how Insulet’s Omnipod 6 and fully closed-loop data could reshape automated insulin delivery for diabetes care.
Find out how Dexcom G7 data could reshape CGM adoption for type 2 diabetes patients not using insulin.
Find out how VolitionRx’s Nu.Q NETs patent filing could reshape Ebola triage, outbreak diagnostics, and treatment monitoring.